Heart Failure Drugs Market Size, Share & Industry Analysis, By Drug Class (SGLT2 Inhibitors, ARNI, Beta Blockers, ACE Inhibitors & ARBs, Mineralocorticoid Receptor Antagonists, Diuretics, and Others), By Indication (HFrEF, HFpEF, HFmrEF, Acute Decompensated Heart Failure, Post-MI Heart Failure / LV Dysfunction, and Others), By Type (Branded and Generics), By Route of Administration (Oral and Parenteral), By Age Group (Adults and Pediatrics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies, and Others), and Regional Forecast, 2026-2034

Last Updated: July 27, 2026 | Format: PDF | Report ID: FBI118447

Buy Now

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 14.06% from 2026-2034
Unit	Value (USD Billion)
Segmentation	By Drug Class, Indication, Type, Route of Administration, Age Group, Distribution Channel, and Region
By Drug Class	SGLT2 Inhibitors ARNI Beta Blockers ACE Inhibitors & ARBs Mineralocorticoid Receptor Antagonists Diuretics Others
By Indication	HFrEF HFpEF HFmrEF Acute Decompensated Heart Failure Post-MI Heart Failure / LV Dysfunction Others
By Type	Branded Generics
By Route of Administration	Oral Parenteral
By Age Group	Adults Pediatrics
By Distribution Channel	Hospital Pharmacies Retail Pharmacies & Drug Stores Online Pharmacies Others
By Region	North America (By Drug Class, Indication, Type, Route of Administration, Age Group, Distribution Channel, and Country) U.S. Canada Europe (By Drug Class, Indication, Type, Route of Administration, Age Group, Distribution Channel, and Country/Sub-region) Germany U.K. France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Drug Class, Indication, Type, Route of Administration, Age Group, Distribution Channel, and Country/Sub-region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Drug Class, Indication, Type, Route of Administration, Age Group, Distribution Channel, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Drug Class, Indication, Type, Route of Administration, Age Group, Distribution Channel, and Country/Sub-region) GCC South Africa Rest of the Middle East & Africa